BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MEN1, ENSG00000133895, 4221 AND Treatment
50 results:

  • 1. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
    Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
    Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.
    Deng J; Liao X; Cao H
    Medicine (Baltimore); 2023 Jul; 102(29):e34350. PubMed ID: 37478229
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
    Navale P; Chatterjee D; Itani M; Trikalinos NA
    Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Insulinoma in childhood: a retrospective review of 22 patients from one referral centre.
    Melikyan M; Gubaeva D; Shadrina A; Bolmasova A; Kareva M; Tiulpakov A; Efremenkov A; Sokolov Y; Brusgaard K; Christesen HT; Andersen K; Stepanov A; Averyanova J; Makarov S; Gurevich L
    Front Endocrinol (Lausanne); 2023; 14():1127173. PubMed ID: 37152923
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Menin-MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and cancers.
    Shi Q; Xu M; Kang Z; Zhang M; Luo Y
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049787
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies.
    Sira L; Zsíros N; Bidiga L; Barna S; Kanyári Z; Nagy EB; Guillaume N; Wild D; Rázsó K; Andó S; Balogh I; Nagy EV; Balogh Z
    Front Endocrinol (Lausanne); 2023; 14():1095815. PubMed ID: 36923225
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE.
    Raj N; Coffman K; Le T; Do RKG; Rafailov J; Choi Y; Chou JF; Capanu M; Dunphy M; Fox JJ; Grewal RK; Reddy RP; Riedl C; Schoder H; Bodei L; Reidy-Lagunes D
    Neuroendocrinology; 2022; 112(12):1177-1186. PubMed ID: 35609558
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
    Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
    [No Abstract]    [Full Text] [Related]  

  • 9. Sunitinib and Evofosfamide (TH-302) in Systemic treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial.
    Grande E; Rodriguez-Antona C; López C; Alonso-Gordoa T; Benavent M; Capdevila J; Teulé A; Custodio A; Sevilla I; Hernando J; Gajate P; Molina-Cerrillo J; Díez JJ; Santos M; Lanillos J; García-Carbonero R
    Oncologist; 2021 Nov; 26(11):941-949. PubMed ID: 34190375
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Impact of
    Cuthbertson DJ; Barriuso J; Lamarca A; Manoharan P; Westwood T; Jaffa M; Fenwick SW; Nuttall C; Lalloo F; Prachalias A; Pizanias M; Wieshmann H; McNamara MG; Hubner R; Srirajaskanthan R; Vivian G; Ramage J; Weickert MO; Pritchard DM; Vinjamuri S; Valle J; Yip VS
    Front Endocrinol (Lausanne); 2021; 12():654975. PubMed ID: 34163434
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Preclinical drug studies in men1-related neuroendocrine neoplasms (men1-NENs).
    Grozinsky-Glasberg S; Lines KE; Avniel-Polak S; Bountra C; Thakker RV
    Endocr Relat Cancer; 2020 Sep; 27(9):R345-R355. PubMed ID: 32590358
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Update on the Surgical treatment of Pancreatic Neuroendocrine Tumors.
    Jeune F; Taibi A; Gaujoux S
    Scand J Surg; 2020 Mar; 109(1):42-52. PubMed ID: 31975647
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Atypical ovarian carcinoid tumor with widespread skeletal metastases: a case report of multiple endocrine neoplasia type 1 in a young woman.
    Lou L; Zhou L; Wang W; Li H; Li Y
    BMC Cancer; 2019 Nov; 19(1):1107. PubMed ID: 31727021
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Management of Ileal Neuroendocrine Tumors with liver Metastases.
    Fisher AT; Titan AL; Foster DS; Worth PJ; Poultsides GA; Visser BC; Dua MM; Norton JA
    J Gastrointest Surg; 2020 Jul; 24(7):1530-1539. PubMed ID: 31346887
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. SET domain containing 1B gene is mutated in primary hepatic neuroendocrine tumors.
    Yang P; Huang X; Lai C; Li L; Li T; Huang P; Ouyang S; Yan J; Cheng S; Lei G; Wang Z; Yu L; Hong Z; Li R; Dong H; Wang C; Yu Y; Wang X; Li X; Wang L; Lv F; Yin Y; Yang H; Song J; Gao Q; Wang X; Zhang S
    Int J Cancer; 2019 Dec; 145(11):2986-2995. PubMed ID: 30977120
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. 18F-FDOPA Uptake Reflects the Efficacy of Dopamine Agonists treatment in Pituitary Prolactinoma.
    Heimburger C; Bund C; Addeo P; Goichot B; Imperiale A
    Clin Nucl Med; 2018 Sep; 43(9):e324-e325. PubMed ID: 30052596
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. DNA methylation profiling in men1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
    Conemans EB; Lodewijk L; Moelans CB; Offerhaus GJA; Pieterman CRC; Morsink FH; Dekkers OM; de Herder WW; Hermus AR; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Brosens LAA; Dreijerink KMA; Borel Rinkes IHM; Timmers HTM; Valk GD; Vriens MR
    Eur J Endocrinol; 2018 Sep; 179(3):153-160. PubMed ID: 29903750
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing.
    Wong HL; Yang KC; Shen Y; Zhao EY; Loree JM; Kennecke HF; Kalloger SE; Karasinska JM; Lim HJ; Mungall AJ; Feng X; Davies JM; Schrader K; Zhou C; Karsan A; Jones SJM; Laskin J; Marra MA; Schaeffer DF; Gorski SM; Renouf DJ
    Cold Spring Harb Mol Case Stud; 2018 Feb; 4(1):. PubMed ID: 29092957
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.
    Ehrlich L; Hall C; Meng F; Lairmore T; Alpini G; Glaser S
    Gene Expr; 2017 Jul; 17(3):251-263. PubMed ID: 28485270
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors - a systematic review and meta-analysis.
    Sallinen V; Le Large TY; Galeev S; Kovalenko Z; Tieftrunk E; Araujo R; Ceyhan GO; Gaujoux S
    HPB (Oxford); 2017 Apr; 19(4):310-320. PubMed ID: 28254159
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.